Skip to content

Exploration Strategies in Night Vision Sensors

Exploration Strategies in Night Vision Sensors

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07352904
Acronym
STRAT-JVN
Enrollment
10
Registered
2026-01-20
Start date
2026-12-01
Completion date
2026-12-25
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Acuity

Keywords

visual strategy, Night Vision Goggles, eyetracking, visual fatigue

Brief summary

The main objective of this clinical trial is to identify a variation in visual strategy characterized by both head movements and eye movements of healthy volunteers during a target detection task when images simulating night vision goggles (NVG) are presented, compared to a situation in which the images simulate a natural environment. To highlight changes in environmental scanning with simulated images from NVG, objective measurements will be collected: * eye movements characterized by saccades (speed, latency, and number) for each stimulus * head movements (horizontal angle of the participant's head) for each stimulus and throughout the exposure Participants sit facing a screen (9.90 m x 2.10 m) onto which a virtual scene is projected. The objective is to correctly identify, as quickly as possible, a target stimulus (represented by a tank) that may appear in the scene. They must use the directional arrows on a game controller to indicate whether the tank is moving to the left or to the right. There are four visits involving four viewing conditions in which the task remains the same: * With restricted field of view and a normal scene. * Without restricted field of view and a scene simulating the vision obtained by NVGs. * With restricted field of view and a scene simulating the vision obtained by NVGs. * Without restricted field of view and a normal scene. Regarding the content of the scene, half of the tests in each visit involve a so-called poor scene when fog is simulated, or an enriched scene when there is no fog. Each visit lasts approximately one hour and thirty minutes.

Interventions

None listed

Sponsors

Direction Centrale du Service de Santé des Armées
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Affiliated with social security; * Normal vision or vision corrected with lenses (far vision ≤ 0.03 log unit (≥ 9/10) OD/OG/binocular); * No current or past ocular or binocular pathology: strabismus or amblyopia; * Signed non-objection form.

Exclusion criteria

* Pregnant or breastfeeding women; * Incapacitated adults; * Individuals who do not understand French (written or spoken).

Design outcomes

Primary

MeasureTime frameDescription
Eye movements characterized by saccades (speed, latency, and number) for each stimulusDay 1 (Visit 1) and during follow-up visits at Day 2 (Visit 2), Day 3 (Visit 3), and Day 4 (Visit 4)Measurements from eyetracker
Head movements (horizontal angle of the participant's head) for each stimulus and throughout the exposureDay 1 (Visit 1) and during follow-up visits at Day 2 (Visit 2), Day 3 (Visit 3), and Day 4 (Visit 4)Measurements extract from motion capture

Secondary

MeasureTime frameDescription
Visual fatigue will be measured using a questionnaireDay 1 (Visit 1) and during follow-up visits at Day 2 (Visit 2), Day 3 (Visit 3), and Day 4 (Visit 4)To highlight subjective visual fatigue generated by changes in visual search strategies using simulated images from night vision sensors.
Number of correct responses to the perceptual taskDay 1 (Visit 1) and during follow-up visits at Day 2 (Visit 2), Day 3 (Visit 3), and Day 4 (Visit 4)Extract with software
The average stimulus detection times.Day 1 (Visit 1) and during follow-up visits at Day 2 (Visit 2), Day 3 (Visit 3), and Day 4 (Visit 4)Measurements from an eyetracker

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 29, 2026